AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2015
Feb 3, 2015
34129_dirs_2015-02-03_e21108ca-a7f3-4af7-b581-f97957d6fedf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2015-02-02
Reporting Person: Wigginton Jon Marc (Sr VP, Clinical)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-02-02 | Common Stock | M | 5000 | $4.7 | Acquired | 5000 | Direct |
| 2015-02-02 | Common Stock | S | 5000 | $31.04 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-02-02 | Employee Stock Option (right to buy) | $4.7 | M | 5000 | Disposed | 2023-07-18 | Common Stock (5000) | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2014.
F2: 12.5% of the shares underlying the option became exercisable on January 19, 2014, and 6.25% of the shares underlying the option become exercisable on the first day of each three month anniversary thereafter.
More from MACROGENICS INC
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Regulatory Filings
2026
May 13
Merger & Acquisition
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Board/Management Information
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18